A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States

**Background:** There has been limited evaluation of medication adherence, healthcare resource utilization (HCRU), and healthcare costs over time in patients with osteoarthritis (OA), and stratification by pain severity level has not been reported. Assessing such longitudinal changes may be useful t...

Full description

Saved in:
Bibliographic Details
Main Authors: Patricia B. Schepman, Sheena Thakkar, Rebecca L. Robinson, Craig G. Beck, Deepa Malhotra, Birol Emir, Ryan N. Hansen
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2022-03-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/jheor.2022.31895
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860370409783296
author Patricia B. Schepman
Sheena Thakkar
Rebecca L. Robinson
Craig G. Beck
Deepa Malhotra
Birol Emir
Ryan N. Hansen
author_facet Patricia B. Schepman
Sheena Thakkar
Rebecca L. Robinson
Craig G. Beck
Deepa Malhotra
Birol Emir
Ryan N. Hansen
author_sort Patricia B. Schepman
collection DOAJ
description **Background:** There has been limited evaluation of medication adherence, healthcare resource utilization (HCRU), and healthcare costs over time in patients with osteoarthritis (OA), and stratification by pain severity level has not been reported. Assessing such longitudinal changes may be useful to patients and healthcare providers for tracking disease progression, informing treatment options, and employing strategies to optimize patient outcomes. **Objectives:** To characterize treatment patterns, HCRU, and costs over time in patients with moderate to severe (MTS) OA pain in the United States. **Methods:** We conducted a retrospective claims analysis, using IBM® MarketScan® databases, from 2013-2018. Eligible patients were aged ≥45 years with ≥12 months pre-index (baseline) and ≥24 months (follow-up) of continuous enrollment; index date was defined as a physician diagnosis of hip or knee OA. An algorithm was employed to identify MTS OA pain patients, who were propensity score matched with patients having non-MTS OA pain. Data were summarized using descriptive statistics and univariate analyses. **Results:** After propensity score matching, the overall OA pain cohorts consisted of 186 374 patients each: 61% were female, mean age was 63 years, and two-thirds (65.6%) were of working age (45-65 years). Sleep-related conditions, anxiety, and depression were significantly higher in the MTS OA pain cohort vs non-MTS (_P_<0.001). At baseline and 12- and 24-month follow-ups, receipt of prescription pain medications, HCRU, and direct medical costs were significantly higher in the MTS OA pain cohort (all _P_<0.01). Medication adherence was significantly higher in the MTS OA pain cohort for all medication classes except analgesics/antipyretics, which were significantly lower vs the non-MTS OA pain cohort (all _P_<0.0001). **Conclusions:** The burden of MTS OA pain is substantial, with patterns that show increasing medication use, HCRU, and costs vs non-MTS OA pain patients over time. Understanding the heterogeneity within the OA population may allow us to further appreciate the true burden of illness for patients in pain.
format Article
id doaj-art-baea60e8fad44b36b700393e87881bac
institution Kabale University
issn 2327-2236
language English
publishDate 2022-03-01
publisher Columbia Data Analytics, LLC
record_format Article
series Journal of Health Economics and Outcomes Research
spelling doaj-art-baea60e8fad44b36b700393e87881bac2025-02-10T16:12:41ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362022-03-0191A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United StatesPatricia B. SchepmanSheena ThakkarRebecca L. RobinsonCraig G. BeckDeepa MalhotraBirol EmirRyan N. Hansen**Background:** There has been limited evaluation of medication adherence, healthcare resource utilization (HCRU), and healthcare costs over time in patients with osteoarthritis (OA), and stratification by pain severity level has not been reported. Assessing such longitudinal changes may be useful to patients and healthcare providers for tracking disease progression, informing treatment options, and employing strategies to optimize patient outcomes. **Objectives:** To characterize treatment patterns, HCRU, and costs over time in patients with moderate to severe (MTS) OA pain in the United States. **Methods:** We conducted a retrospective claims analysis, using IBM® MarketScan® databases, from 2013-2018. Eligible patients were aged ≥45 years with ≥12 months pre-index (baseline) and ≥24 months (follow-up) of continuous enrollment; index date was defined as a physician diagnosis of hip or knee OA. An algorithm was employed to identify MTS OA pain patients, who were propensity score matched with patients having non-MTS OA pain. Data were summarized using descriptive statistics and univariate analyses. **Results:** After propensity score matching, the overall OA pain cohorts consisted of 186 374 patients each: 61% were female, mean age was 63 years, and two-thirds (65.6%) were of working age (45-65 years). Sleep-related conditions, anxiety, and depression were significantly higher in the MTS OA pain cohort vs non-MTS (_P_<0.001). At baseline and 12- and 24-month follow-ups, receipt of prescription pain medications, HCRU, and direct medical costs were significantly higher in the MTS OA pain cohort (all _P_<0.01). Medication adherence was significantly higher in the MTS OA pain cohort for all medication classes except analgesics/antipyretics, which were significantly lower vs the non-MTS OA pain cohort (all _P_<0.0001). **Conclusions:** The burden of MTS OA pain is substantial, with patterns that show increasing medication use, HCRU, and costs vs non-MTS OA pain patients over time. Understanding the heterogeneity within the OA population may allow us to further appreciate the true burden of illness for patients in pain.https://doi.org/10.36469/jheor.2022.31895
spellingShingle Patricia B. Schepman
Sheena Thakkar
Rebecca L. Robinson
Craig G. Beck
Deepa Malhotra
Birol Emir
Ryan N. Hansen
A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States
Journal of Health Economics and Outcomes Research
title A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States
title_full A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States
title_fullStr A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States
title_full_unstemmed A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States
title_short A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States
title_sort retrospective claims based study evaluating clinical and economic burden among patients with moderate to severe osteoarthritis pain in the united states
url https://doi.org/10.36469/jheor.2022.31895
work_keys_str_mv AT patriciabschepman aretrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT sheenathakkar aretrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT rebeccalrobinson aretrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT craiggbeck aretrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT deepamalhotra aretrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT birolemir aretrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT ryannhansen aretrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT patriciabschepman retrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT sheenathakkar retrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT rebeccalrobinson retrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT craiggbeck retrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT deepamalhotra retrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT birolemir retrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates
AT ryannhansen retrospectiveclaimsbasedstudyevaluatingclinicalandeconomicburdenamongpatientswithmoderatetosevereosteoarthritispainintheunitedstates